MDT - Medtronic plc
NYSE
->
Healthcare
->
Medical Devices
Dublin,
Ireland
Type: Equity
MDT price evolution
MDT
| (in millions $) | 26 Feb 2024 | 31 Jan 2024 | 28 Aug 2023 | 28 May 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1623 | $1311 | $1339 | |
| Short term investments | $6698 | $6423 | $6537 | |
| Net receivables | $5968 | $5934 | $5806 | $5998 |
| Inventory | $5726 | $5754 | $5668 | $5293 |
| Total current assets | $22513 | $22081 | $21869 | $21675 |
| Long term investments | ||||
| Property, plant & equipment | $5838 | $5735 | $5665 | $5569 |
| Goodwill & intangible assets | $54850 | $54881 | $55870 | |
| Total noncurrent assets | $68323 | $68006 | $68907 | |
| Total investments | $6698 | $6423 | $6537 | |
| Total assets | $90836 | $90087 | $90776 | $90948 |
| Current liabilities | ||||
| Accounts payable | $1992 | $2174 | $2239 | $2662 |
| Deferred revenue | ||||
| Short long term debt | $1029 | $1339 | $519 | |
| Total current liabilities | $9793 | $9659 | $9047 | $9051 |
| Long term debt | $24153 | $23741 | $24463 | $24344 |
| Total noncurrent liabilities | $29047 | $28781 | $30363 | |
| Total debt | $25182 | $25080 | $24982 | |
| Total liabilities | $39044 | $38627 | $39598 | $39465 |
| Shareholders' equity | ||||
| Retained earnings | $30661 | $30256 | $30265 | $30392 |
| Other shareholder equity | -$3458.13 | -$3080 | -$3674.13 | -$3241.13 |
| Total shareholder equity | $51792 | $51460 | $51178 | |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $1543 | $3714 | $3593 | $4140 |
| Short term investments | $6416 | $6859 | $7224 | $6808 |
| Net receivables | $5998 | $5551 | $5462 | $4645 |
| Inventory | $5293 | $4616 | $4313 | $4229 |
| Total current assets | $21675 | $23059 | $22548 | $22031 |
| Long term investments | ||||
| Property, plant & equipment | $5569 | $5413 | $5221 | $4828 |
| Goodwill & intangible assets | $56269 | $56097 | $59701 | $58904 |
| Total noncurrent assets | $69273 | $67922 | $70535 | $68658 |
| Total investments | $6416 | $6859 | $7224 | $6808 |
| Total assets | $90948 | $90981 | $93083 | $90689 |
| Current liabilities | ||||
| Accounts payable | $2662 | $2276 | $2106 | $1996 |
| Deferred revenue | ||||
| Short long term debt | $20 | $3742 | $11 | $2776 |
| Total current liabilities | $9051 | $12394 | $8509 | $10366 |
| Long term debt | $24344 | $20372 | $26378 | $22021 |
| Total noncurrent liabilities | $30232 | $25866 | $32972 | $29451 |
| Total debt | $24364 | $24114 | $26389 | $24797 |
| Total liabilities | $39283 | $38260 | $41481 | $39817 |
| Shareholders' equity | ||||
| Retained earnings | $30392 | $30250 | $28594 | $28132 |
| Other shareholder equity | -$3499 | -$2265 | -$3485 | -$3560 |
| Total shareholder equity | $51483 | $52551 | $51428 | $50737 |
| (in millions $) | 26 Feb 2024 | 31 Jan 2024 | 28 Aug 2023 | 28 May 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $8089 | $7702 | $8545 | |
| Cost of revenue | ||||
| Gross Profit | $5349 | $5074 | $5596 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $3726 | $3712 | $3585 | |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $135 | $400 | $362 | |
| Interest expense | -$188 | -$148 | -$36 | |
| Net income | ||||
| Net income | $1322 | $791 | $1179 | |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $31686 | $30117 | $28913 | |
| Cost of revenue | $10145 | $10483 | $9424 | |
| Gross Profit | $21541 | $19634 | $19489 | |
| Operating activities | ||||
| Research & development | $2746 | $2493 | $2331 | |
| Selling, general & administrative | $10292 | $10148 | $10109 | |
| Total operating expenses | $15788 | $15150 | $14698 | |
| Operating income | $5753 | $4484 | $4791 | |
| Income from continuing operations | ||||
| EBIT | $6048 | $4796 | $5130 | |
| Income tax expense | $456 | $265 | -$751 | |
| Interest expense | $553 | $925 | $1092 | |
| Net income | ||||
| Net income | $5039 | $3606 | $4789 | |
| Income (for common shares) | $5039 | $3606 | $4789 | |
| (in millions $) | 26 Feb 2024 | 27 Nov 2023 | 28 Aug 2023 | 28 May 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$1670 | -$963 | -$539 | -$3493 |
| Financing activities | ||||
| Dividends paid | -$2753 | -$1836 | -$918 | -$3616 |
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$2091 | -$591 | -$501 | -$4960 |
| Effect of exchange rate | -$170 | -$214 | -$39 | $243 |
| Change in cash and equivalents | $80 | -$232 | -$204 | -$2171 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $3758 | $5039 | $3606 | $4789 |
| Operating activities | ||||
| Depreciation | $2697 | $2707 | $2702 | $2663 |
| Business acquisitions & disposals | -$1867 | -$91 | -$994 | -$488 |
| Stock-based compensation | $355 | $359 | $344 | $297 |
| Total cash flows from operations | $6039 | $7346 | $6240 | $7234 |
| Investing activities | ||||
| Capital expenditures | -$1459 | -$1368 | -$1355 | -$1213 |
| Investments | -$171 | -$190 | -$463 | -$1465 |
| Total cash flows from investing | -$3493 | -$1659 | -$2866 | -$3203 |
| Financing activities | ||||
| Dividends paid | -$3616 | -$3383 | -$3120 | -$2894 |
| Sale and purchase of stock | -$337 | -$2115 | -$178 | -$664 |
| Net borrowings | -$598 | -$1 | -$570 | -$559 |
| Total cash flows from financing | -$4960 | -$5336 | -$4136 | -$4198 |
| Effect of exchange rate | $243 | -$231 | $215 | -$86 |
| Change in cash and equivalents | -$2171 | $121 | -$547 | -$253 |
News
Fundamentals
| Market cap | $107.13B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 1.33B |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 4.68% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.76 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.30 |
| Quick ratio | 1.71 |